- call +1-201-465-4211
- email sales@mrinsights.biz
Geriatrics, or geriatric medicine, is a specialty that focuses on health care of elderly people. It aims to promote health by preventing and treating diseases and disabilities in older adults.
Scope of the Report:
The global Geriatric Medicines market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Geriatric Medicines.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Geriatric Medicines market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Geriatric Medicines market by product type and applications/end industries.
Market Segment by Companies, this report covers
Eli Lilly and Company
AstraZeneca
Boehringer Ingelheim
Abbott Laboratories
Sanofi
Bristol-Myers Squibb
Merck
Novartis
Pfizer
GSK
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Analgesics
Antihypertensives
Statins
Antidiabetics
Proton Pump Inhibitor
Anticoagulant
Antipsychotics
Antidepressants
Market Segment by Applications, can be divided into
Cardiovascular diseases
Arthritis
Neurological Disorders
Cancer
Osteoporosis
Respiratory
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Geriatric Medicines Market Overview
1.1 Product Overview and Scope of Geriatric Medicines
1.2 Classification of Geriatric Medicines by Types
1.2.1 Global Geriatric Medicines Revenue Comparison by Types (2017-2023)
1.2.2 Global Geriatric Medicines Revenue Market Share by Types in 2017
1.2.3 Analgesics
1.2.4 Antihypertensives
1.2.5 Statins
1.2.6 Antidiabetics
1.2.7 Proton Pump Inhibitor
1.2.8 Anticoagulant
1.2.9 Antipsychotics
1.2.10 Antidepressants
1.3 Global Geriatric Medicines Market by Application
1.3.1 Global Geriatric Medicines Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Cardiovascular diseases
1.3.3 Arthritis
1.3.4 Neurological Disorders
1.3.5 Cancer
1.3.6 Osteoporosis
1.3.7 Respiratory
1.4 Global Geriatric Medicines Market by Regions
1.4.1 Global Geriatric Medicines Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Geriatric Medicines Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Geriatric Medicines Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Geriatric Medicines Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Geriatric Medicines Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Geriatric Medicines Status and Prospect (2013-2023)
1.5 Global Market Size of Geriatric Medicines (2013-2023)
2 Manufacturers Profiles
2.1 Eli Lilly and Company
2.1.1 Business Overview
2.1.2 Geriatric Medicines Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Eli Lilly and Company Geriatric Medicines Revenue, Gross Margin and Market Share (2016-2017)
2.2 AstraZeneca
2.2.1 Business Overview
2.2.2 Geriatric Medicines Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 AstraZeneca Geriatric Medicines Revenue, Gross Margin and Market Share (2016-2017)
2.3 Boehringer Ingelheim
2.3.1 Business Overview
2.3.2 Geriatric Medicines Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Boehringer Ingelheim Geriatric Medicines Revenue, Gross Margin and Market Share (2016-2017)
2.4 Abbott Laboratories
2.4.1 Business Overview
2.4.2 Geriatric Medicines Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Abbott Laboratories Geriatric Medicines Revenue, Gross Margin and Market Share (2016-2017)
2.5 Sanofi
2.5.1 Business Overview
2.5.2 Geriatric Medicines Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Sanofi Geriatric Medicines Revenue, Gross Margin and Market Share (2016-2017)
2.6 Bristol-Myers Squibb
2.6.1 Business Overview
2.6.2 Geriatric Medicines Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bristol-Myers Squibb Geriatric Medicines Revenue, Gross Margin and Market Share (2016-2017)
2.7 Merck
2.7.1 Business Overview
2.7.2 Geriatric Medicines Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Merck Geriatric Medicines Revenue, Gross Margin and Market Share (2016-2017)
2.8 Novartis
2.8.1 Business Overview
2.8.2 Geriatric Medicines Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Novartis Geriatric Medicines Revenue, Gross Margin and Market Share (2016-2017)
2.9 Pfizer
2.9.1 Business Overview
2.9.2 Geriatric Medicines Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Pfizer Geriatric Medicines Revenue, Gross Margin and Market Share (2016-2017)
2.10 GSK
2.10.1 Business Overview
2.10.2 Geriatric Medicines Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 GSK Geriatric Medicines Revenue, Gross Margin and Market Share (2016-2017)
3 Global Geriatric Medicines Market Competition, by Players
3.1 Global Geriatric Medicines Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Geriatric Medicines Players Market Share
3.2.2 Top 10 Geriatric Medicines Players Market Share
3.3 Market Competition Trend
4 Global Geriatric Medicines Market Size by Regions
4.1 Global Geriatric Medicines Revenue and Market Share by Regions
4.2 North America Geriatric Medicines Revenue and Growth Rate (2013-2018)
4.3 Europe Geriatric Medicines Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Geriatric Medicines Revenue and Growth Rate (2013-2018)
4.5 South America Geriatric Medicines Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Geriatric Medicines Revenue and Growth Rate (2013-2018)
5 North America Geriatric Medicines Revenue by Countries
5.1 North America Geriatric Medicines Revenue by Countries (2013-2018)
5.2 USA Geriatric Medicines Revenue and Growth Rate (2013-2018)
5.3 Canada Geriatric Medicines Revenue and Growth Rate (2013-2018)
5.4 Mexico Geriatric Medicines Revenue and Growth Rate (2013-2018)
6 Europe Geriatric Medicines Revenue by Countries
6.1 Europe Geriatric Medicines Revenue by Countries (2013-2018)
6.2 Germany Geriatric Medicines Revenue and Growth Rate (2013-2018)
6.3 UK Geriatric Medicines Revenue and Growth Rate (2013-2018)
6.4 France Geriatric Medicines Revenue and Growth Rate (2013-2018)
6.5 Russia Geriatric Medicines Revenue and Growth Rate (2013-2018)
6.6 Italy Geriatric Medicines Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Geriatric Medicines Revenue by Countries
7.1 Asia-Pacific Geriatric Medicines Revenue by Countries (2013-2018)
7.2 China Geriatric Medicines Revenue and Growth Rate (2013-2018)
7.3 Japan Geriatric Medicines Revenue and Growth Rate (2013-2018)
7.4 Korea Geriatric Medicines Revenue and Growth Rate (2013-2018)
7.5 India Geriatric Medicines Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Geriatric Medicines Revenue and Growth Rate (2013-2018)
8 South America Geriatric Medicines Revenue by Countries
8.1 South America Geriatric Medicines Revenue by Countries (2013-2018)
8.2 Brazil Geriatric Medicines Revenue and Growth Rate (2013-2018)
8.3 Argentina Geriatric Medicines Revenue and Growth Rate (2013-2018)
8.4 Colombia Geriatric Medicines Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Geriatric Medicines by Countries
9.1 Middle East and Africa Geriatric Medicines Revenue by Countries (2013-2018)
9.2 Saudi Arabia Geriatric Medicines Revenue and Growth Rate (2013-2018)
9.3 UAE Geriatric Medicines Revenue and Growth Rate (2013-2018)
9.4 Egypt Geriatric Medicines Revenue and Growth Rate (2013-2018)
9.5 Nigeria Geriatric Medicines Revenue and Growth Rate (2013-2018)
9.6 South Africa Geriatric Medicines Revenue and Growth Rate (2013-2018)
10 Global Geriatric Medicines Market Segment by Type
10.1 Global Geriatric Medicines Revenue and Market Share by Type (2013-2018)
10.2 Global Geriatric Medicines Market Forecast by Type (2018-2023)
10.3 Analgesics Revenue Growth Rate (2013-2023)
10.4 Antihypertensives Revenue Growth Rate (2013-2023)
10.5 Statins Revenue Growth Rate (2013-2023)
10.6 Antidiabetics Revenue Growth Rate (2013-2023)
10.7 Proton Pump Inhibitor Revenue Growth Rate (2013-2023)
10.8 Anticoagulant Revenue Growth Rate (2013-2023)
10.9 Antipsychotics Revenue Growth Rate (2013-2023)
10.10 Antidepressants Revenue Growth Rate (2013-2023)
11 Global Geriatric Medicines Market Segment by Application
11.1 Global Geriatric Medicines Revenue Market Share by Application (2013-2018)
11.2 Geriatric Medicines Market Forecast by Application (2018-2023)
11.3 Cardiovascular diseases Revenue Growth (2013-2018)
11.4 Arthritis Revenue Growth (2013-2018)
11.5 Neurological Disorders Revenue Growth (2013-2018)
11.6 Cancer Revenue Growth (2013-2018)
11.7 Osteoporosis Revenue Growth (2013-2018)
11.8 Respiratory Revenue Growth (2013-2018)
12 Global Geriatric Medicines Market Size Forecast (2018-2023)
12.1 Global Geriatric Medicines Market Size Forecast (2018-2023)
12.2 Global Geriatric Medicines Market Forecast by Regions (2018-2023)
12.3 North America Geriatric Medicines Revenue Market Forecast (2018-2023)
12.4 Europe Geriatric Medicines Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Geriatric Medicines Revenue Market Forecast (2018-2023)
12.6 South America Geriatric Medicines Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Geriatric Medicines Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Geriatric Medicines Picture
Table Product Specifications of Geriatric Medicines
Table Global Geriatric Medicines and Revenue (Million USD) Market Split by Product Ty
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
